Alcohol misuse in patients with psoriasis: Identification and relationship to disease severity and psychological distress

British Journal of Dermatology

Volumn 164, Issue 6, 2011, Pages 1256-1261

  McAleer, M A ^a   Mason, D L ^b   Cunningham, S ^a   O'Shea, S J ^a   McCormick, P A ^a   Stone, C ^c   Collins, P ^a   Rogers, S ^a   Kirby, B ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b BRADFORD DISTRICT CARE NHS FOUNDATION TRUST   (United Kingdom)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BIOLOGICAL MARKER; CARBOHYDRATE DEFICIENT TRANSFERRIN; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOL USE DISORDERS IDENTIFICATION TEST; ANXIETY DISORDER; ARTICLE; CHRONIC DISEASE; COHORT ANALYSIS; DEPRESSION; DISEASE SEVERITY; DISTRESS SYNDROME; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENDER; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; PSORIASIS VULGARIS; QUALITY OF LIFE; QUESTIONNAIRE; SCREENING TEST;

ADULT; AGE FACTORS; AGED; ALCOHOL DRINKING; ALCOHOL-RELATED DISORDERS; ANXIETY DISORDERS; BIOLOGICAL MARKERS; DEPRESSIVE DISORDER; EPIDEMIOLOGIC METHODS; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; QUALITY OF LIFE; SEX FACTORS; STRESS, PSYCHOLOGICAL; TRANSFERRIN;

EID: 79957619190     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10345.x     Document Type: Article

References (36)

1. Braathen LR, Botten G, Bjerkedal T,. Psoriatics in Norway. A questionnaire study on health status, contact with paramedical professions, and alcohol and tobacco consumption. Acta Derm Venereol Suppl 1989; 142: 9-12. (Pubitemid 19163997)
2. Kirby B, Richards HL, Mason DL, et al. Alcohol consumption and psychological distress in patients with psoriasis. Br J Dermatol 2008; 158: 138-46.
3. Poikolainen K, Karvonen J, Pukkala E,. Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. Arch Dermatol 1999; 135: 1490-3.
4. Tobin AM, Higgins EM, Norris S, Kirby B,. Prevalence of psoriasis in patients with alcoholic liver disease. Clin Exp Dermatol 2009; 34: 698-701.
5. Poikolainen K, Renuala T, Karvonen J,. Smoking, alcohol and life events related to psoriasis among women. Br J Dermatol 1994; 130: 473-7. (Pubitemid 24204666)
6. Tobin AM, Kirby B,. Psoriasis: an opportunity to identify cardiovascular risk. Br J Dermatol 2009; 161: 691-720.
7. Gupta MA, Schork NJ, Gupta AK, et al. Alcohol intake and treatment responsiveness of psoriasis: a prospective study. J Am Acad Dermatol 1993; 28: 730-2. (Pubitemid 23133383)
8. Higgins E,. Alcohol, smoking and psoriasis. Clin Exp Dermatol 2000; 25: 107-10.
9. Alling C, Chick JD, Anton R, et al. Revealing alcohol abuse: to ask or to test? Alcohol Clin Exp Res 2005; 29: 1257-63. (Pubitemid 41060442)
10. Lemmens PH,. The alcohol content of self-report and 'standard' drinks. Addiction 1994; 89: 593-601. (Pubitemid 24160088)
11. Neumann T, Spies C,. Use of biomarkers for alcohol use disorders in clinical practice. Addiction 2003; 98: 81-91. (Pubitemid 38030765)
12. Das SK, Dhanya L, Vasudevan DM,. Biomarkers of alcoholism: an updated review. Scand J Clin Lab Invest 2007; 68: 81-92. (Pubitemid 351481734)
13. Bergström JP, Helander A,. Clinical characteristics of carbohydrate-deficient transferrin (%disialotransferrin) measured by HPLC: sensitivity, specificity, gender effects, and relationship with other alcohol biomarkers. Alcohol Alcohol 2008; 43: 436-41. (Pubitemid 351965912)
14. Rinck D, Frieling H, Freitag A, et al. Combinations of carbohydrate-deficient transferrin, mean corpuscular erythrocyte volume, gamma-glutamyltransferase, homocysteine and folate increase the significance of biological markers in alcohol patients. Drug Alcohol Depend 2007; 89: 60-5. (Pubitemid 46602876)
15. Kraemer KL, Smith KJ, Roberts MA,. Cost-effectiveness of screening for unhealthy alcohol use with %carbohydrate deficient transferrin: results from a literature-based decision analytic computer model. Alcohol Clin Exp Res 2009; 33: 1-10.
16. Fleming M, Bhamb B, Schurr M, et al. Alcohol biomarkers in patients admitted for trauma. Alcohol Clin Exp Res 2009; 33: 1777-81.
17. Bergström JP, Helander A,. Influence of alcohol use, ethnicity, age, gender, BMI and smoking on the serum transferrin glycoform pattern: implications for use of carbohydrate-deficient transferrin (CDT) as alcohol biomarker. Clin Chim Acta 2008; 388: 59-67. (Pubitemid 350266569)
18. Hoefkens P, Higgins EM, Ward RJ, et al. Isoforms of transferrin in psoriasis patients abusing alcohol. Alcohol Alcohol 1997; 32: 195-9. (Pubitemid 27151916)
19. Fredriksson T, Pettersson U,. Severe psoriasis: oral therapy with a new retinoid. Dermatology 1978; 157: 238-44. (Pubitemid 8387357)
20. Feldman SR, Fleischer AB Jr, Reboussin DM, et al. The self-administered Psoriasis Area and Severity Index is valid and reliable. J Invest Dermatol 1996; 106: 183-6. (Pubitemid 26052065)
21. Basra MKA, Fenech R, Gatt RM, et al. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008; 159: 997-1035.
22. Zigmond A, Snaith R,. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361-70. (Pubitemid 13098606)
23. Fortune DG, Richards HL, Main CJ, Griffiths CEM,. Pathological worrying, illness perceptions and disease severity in patients with psoriasis. Br J Health Psychol 2000; 5: 71-82. (Pubitemid 30088786)
24. Wessley SC, Lewis GH,. The classification of psychiatric morbidity in attenders at a dermatology clinic. Br J Dermatol 1989; 155: 686-91. (Pubitemid 19269077)
25. Meyer TJ, Miller ML, Metzger RL, Borkovec TD,. Development and validation of the Penn State Worry Questionnaire. Behav Res Ther 1990; 28: 487-95.
26. Selzer ML,. The Michigan Alcoholism Screening Test: the quest for a new diagnostic instrument. Am J Psychiatry 1971; 127: 1653-8.
27. Mayfield D, McLeod G, Hall P,. The CAGE questionnaire: validation of a new alcoholism instrument. Am J Psychiatry 1974; 131: 1121-3.
28. Reinert DF, Allen JP,. The alcohol use disorders identification test: an update of research findings. Alcohol Clin Exp Res 2007; 31: 185-99. (Pubitemid 46155217)
29. Persijn JP, van der Slik W,. A new method for the determination of γ-glutamyltransferase. J Clin Chem Clin Biochem 1976; 14: 421-7.
30. Schellenberg F, Girre C, Nalpas B, et al. Analytical evaluation of a new capillary electrophoresis method for carbohydrate-deficient transferrin measurement. Clin Chim Acta 2007; 382: 48-53. (Pubitemid 46782733)
31. Fiellin DA, Reid MC, O'Connor PG,. Screening for alcohol problems in primary care: a systemic review. Arch Intern Med 2000; 160: 1977-89. (Pubitemid 30437582)
32. Lapham SC, Brown P, Suriyawongpaisal P, et al. Use of AUDIT for alcohol screening among emergency room patients in Thailand. Alcohol Use Disorders Identification Test. Subst Use Misuse 1999; 34: 1881-95. (Pubitemid 29503122)
33. Stein MD, Charuvastra A, Anderson B, et al. Alcohol and HIV risk taking among intravenous drug users. Addict Behav 2002; 27: 727-36. (Pubitemid 34712053)
34. Claussen B, Aasland OG,. The Alcohol Use Disorders Identification Test (AUDIT) in a routine health examination of long-term unemployed. Addiction 1993; 88: 363-8. (Pubitemid 23095977)
35. Demartini KS, Carey KB,. Correlates of AUDIT risk status for male and female college students. J Am Coll Health 2009; 58: 233-9.
36. Gomez A, Conde A, Santana JM, et al. The diagnostic usefulness of AUDIT and AUDIT-C for detecting hazardous drinkers in the elderly. Aging Ment Health 2006; 10: 558-61. (Pubitemid 44567662)